$CNAT reports 4Q loss

Biotech Stocks

Conatus reports 4Q loss

Conatus Pharmaceuticals posts loss of $5.3 million in fourth quarter

SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $5.3 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 34 cents.

For the year, the company reported profit of $22.3 million, or $1.44 per share.

Conatus shares have decreased 19 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.66, a drop of 54 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at http://www.zacks.com/ap/CNAT


Keywords: Conatus Pharmaceuticals, Earnings Report


Please enter your comment!
Please enter your name here